Abstract
Liquid-based disinfection of environmental surfaces is a momentary intervention while the recontamination of these surfaces is continuous. In between disinfection cycles, contaminated surfaces remain a potential source of infection. The use of continuously active antimicrobial surface coatings would reduce the risk of transmission between routine cleaning and liquid disinfection events by serving as an “always-on” approach to reduce pathogen burden. We have recently reported on a surface coating having antiviral properties. Here, the spectrum of activity was broadened assessment efficacy of the coating to withstand multiple contamination events against viruses and pathogenic bacteria.
Competing Interest Statement
Financial Support: The virus tests and assays performed for this study were funded by Allied Biosciences to the University of Arizona, whose researchers participated in the study design. Conflict of Interest: The University of Arizona authors have no conflict of interest to report. Valerie Beck is an employee of Allied Bioscience Inc. The conduct of the study, analysis, and presentation of the results as well as the decision to publish were solely determined by the authors without influence by the funding source.
Funding Statement
Financial Support: The virus tests and assays performed for this study were funded by Allied Biosciences to the University of Arizona, whose researchers participated in the study design
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No clinical trials involved and IRB not required
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Available to the public upon request
